XML 49 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
SEGMENT INFORMATION
 6 Months Ended
Mar. 31, 2014
SEGMENT INFORMATION [Abstract]  
SEGMENT INFORMATION
  5. SEGMENT INFORMATION

 

We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to Consolidated Financial Statements in our annual report on Form 10-K for the year ended September 30, 2013.

 

    Three Months Ended
March 31,		     Six Months Ended
March 31,		  
    2014     2013     2014     2013  
                         
Revenue:                                
Service   $ 4,526     $ 3,667     $ 9,442     $ 8,337  
Product     1,386       1,489       2,690       2,623  
    $ 5,912     $ 5,156     $ 12,132     $ 10,960  
                                 
Operating income (loss):                                
Service   $ (38 )   $ (365 )   $ 377     $ (150 )
Product     143       356       190       444  
    $ 105     $ (9 )   $ 567     $ 294  
                                 
Interest expense     (121 )     (163 )     (285 )     (329 )
Change in fair value of warrant liability - increase     (200 )     (142 )     (1,161 )     (25 )
Other income     4       3       5       5  
                                 
Loss before income taxes   $ (212 )   $ (311 )   $ (874 )   $ (55 )